Cerebrovascular Events After TAVR May Be Especially Serious

Stroke events do not seem to be related to valve thrombosis or structural degeneration, but to a higher baseline risk in patients who undergo transcatheter aortic valve replacement (TAVR).

Efectos de la radiación cerebral en Cardiólogos Intervencionistas

About 1 in 20 patients who underwent TAVR experienced a stroke or transient ischemic attack during follow-up. According to this new analysis, the consequences of these events can be particularly catastrophic for the aforementioned population.

Most late strokes that occurred were disabling, and nearly one-third of patients who had them died during hospitalization.

While we wonder what can be done to mitigate the impact of these events, we can identify some certainties. There was echocardiographic data available for 58% of patients at the time of the cerebrovascular event, and the analysis did not suggest a relation between these events and valve thrombosis or structural valve degeneration.


Read also: Heart and Brain: Risk Factors, Atrial Fibrillation and Dementia.


In this sense, this work sheds some light on valve thrombosis. The vast majority of strokes occurred either at 1 year or later; consequently, thrombosis is not likely to be involved in the mechanism, since it is an event that seems to peak in the initial days and weeks following the procedure.

Of 3750 consecutive patients who underwent TAVR and survived beyond 30 days, 192 patients (5.1%) had a late cerebrovascular event, as was defined using the VARC-2 criteria, at a mean 16 months after the initial procedure. About 80% of all stroke events were ischemic, and all others were hemorrhagic.

Such stroke events were disabling for 70% of this population; the affected patients remaining died during hospitalization. These catastrophic results seem to be worse than the outcomes in a general population of similarly-aged patients, and comorbidities are apparently the key.


Read also: MR CLEAN Registry: “Time is Brain” is a Far More Accurate than “Time is Heart”.


The best predictor of late stroke after TAVR was prior stroke.

Original Title: Late cerebrovascular events following transcatheter aortic valve replacement.

Reference: Muntané-Carol G et al. J Am Coll Cardiol Intv. 2020; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...